Počet záznamů: 1
Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial
- 1.Bielcikova, Z., Werner, L., Štursa, J., Černý, V., Křížová, L., Špaček, J., Hlousek, S., Vočka, M., Bartosova, O., Pesta, M., Kološtová, K., Klezl, P., Bobek, V., Truksa, J., Štemberková-Hubáčková, S., Petruzelka, L., Michálek, P., Neužil, J. Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial. Therapeutic Advances in Medical Oncology. 2023, 15(March 28), 17588359231197957. ISSN 1758-8340. E-ISSN 1758-8359. Dostupné z: https://doi.org/10.1177/17588359231197957.
Počet záznamů: 1